4.7 Article

Complement Activation Products in Patients with Chronic Schizophrenia

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis

Meike Heurich et al.

Summary: Early identification and treatment play a crucial role in improving clinical outcomes of psychotic disorders. Recent studies have identified specific protein alterations in the complement and coagulation systems, which are implicated in psychosis and can predict the transition to psychotic disorder. Further research is needed to validate the novel hypothesis regarding altered plasma levels of complement and coagulation proteins.

MOLECULAR PSYCHIATRY (2022)

Article Environmental Sciences

Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients

Katarzyna Waszczuk et al.

Summary: This study investigates the potential role of stem cells and immune factors in the etiology of schizophrenia. Although preliminary findings suggest the importance of the immune system and regenerative processes, further studies are needed.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Biochemistry & Molecular Biology

Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress

Melanie Focking et al.

Summary: The study found that dysregulation of the complement protein pathway in blood is associated with the incidence of psychotic experiences in individuals with psychiatric disorders.

MOLECULAR PSYCHIATRY (2021)

Review Biochemistry & Molecular Biology

The complement system in schizophrenia: where are we now and what's next?

Julia J. Woo et al.

MOLECULAR PSYCHIATRY (2020)

Review Clinical Neurology

Complement in neurological disorders and emerging complement-targeted therapeutics

Marinos C. Dalakas et al.

NATURE REVIEWS NEUROLOGY (2020)

Article Neurosciences

Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis

Alexis E. Cullen et al.

BIOLOGICAL PSYCHIATRY (2019)

Review Neurosciences

Synaptic Elimination in Neurological Disorders

Pablo L. Cardozo et al.

CURRENT NEUROPHARMACOLOGY (2019)

Review Clinical Neurology

The genomics of schizophrenia: Shortcomings and solutions

Chuanjun Zhuo et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Article Psychiatry

Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure

Alan Shafer et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

Article Psychiatry

Investigation of peripheral complement factors across stages of psychosis

Liliana Laskaris et al.

SCHIZOPHRENIA RESEARCH (2019)

Article Neurosciences

Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans

Dana M. Allswede et al.

NEUROPSYCHOPHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia

Takashi Ishii et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Developmental activities of the complement pathway in migrating neurons

Anna Gorelik et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

Novel mechanisms and functions of complement

George Hajishengallis et al.

NATURE IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

B. S. Fernandes et al.

MOLECULAR PSYCHIATRY (2016)

Article Multidisciplinary Sciences

Schizophrenia risk from complex variation of complement component 4

Aswin Sekar et al.

NATURE (2016)

Article Psychiatry

Dose Equivalents for Antipsychotic Drugs: The DDD Method

Stefan Leucht et al.

SCHIZOPHRENIA BULLETIN (2016)

Article Multidisciplinary Sciences

Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients

Jordan M. Ramsey et al.

PLOS ONE (2013)

Article Biochemistry & Molecular Biology

Identification of a biological signature for schizophrenia in serum

E. Schwarz et al.

MOLECULAR PSYCHIATRY (2012)

Article Psychiatry

Childhood infection and adult schizophrenia: A meta-analysis of population-based studies

Golam M. Khandaker et al.

SCHIZOPHRENIA RESEARCH (2012)

Article Biochemistry & Molecular Biology

Alternative Complement Pathway in Schizophrenia

Anna Boyajyan et al.

NEUROCHEMICAL RESEARCH (2010)

Review Neurosciences

Minocycline: A Neuroprotective Agent for Hypoxic-Ischemic Brain Injury in the Neonate?

Kathryn M. Buller et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2009)

Article Pharmacology & Pharmacy

The complement system in schizophrenia

Karine R. Mayilyan et al.

DRUG NEWS & PERSPECTIVES (2008)

Article Biochemistry & Molecular Biology

The classical complement cascade mediates CNS synapse elimination

Beth Stevens et al.

Review Immunology

Cytokines in schizophrenia and the effects of antipsychotic drugs

Lukasz Drzyzga et al.

BRAIN BEHAVIOR AND IMMUNITY (2006)

Review Biochemistry & Molecular Biology

Complement: a unique innate immune sensor for danger signals

P Gasque

MOLECULAR IMMUNOLOGY (2004)

Review Psychiatry

Obstetric complications and schizophrenia: Historical and meta-analytic review

M Cannon et al.

AMERICAN JOURNAL OF PSYCHIATRY (2002)

Review Psychiatry

Effects of antipsychotic drugs on cytokine networks

T Pollmächer et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2000)

Article Psychiatry

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

LA Glantz et al.

ARCHIVES OF GENERAL PSYCHIATRY (2000)